Literature DB >> 15653237

In vitro ablation of cardiac valves using high-intensity focused ultrasound.

Ryo Otsuka1, Kana Fujikura, Kumiko Hirata, Todd Pulerwitz, Yukiko Oe, Takeki Suzuki, Robert Sciacca, Charles Marboe, Jie Wang, Daniel Burkhoff, Robert Muratore, Frederic L Lizzi, Shunichi Homma.   

Abstract

The purpose of this study was to evaluate the possibility of using high-intensity focused ultrasound (US), or HIFU, to create lesions in cardiac valves in vitro. Calf mitral valves and aortic valves were examined. Focused US energy was applied with an operating frequency of 4.67 MHz at a nominal acoustic power of 58 W for 0.2, 0.3 and 0.4 s at 4-s intervals. Mitral valve perforation was achieved with 20.8 +/- 3.7 exposures of 0.2 s, 15.4 +/- 2.1 exposures of 0.3 s or 11.2 +/- 2.3 exposures of 0.4 s. Aortic valve perforation was achieved with 13.3 +/- 2.4 exposures of 0.2 s, 10.3 +/- 2.2 exposures of 0.3 s or 8.4 +/- 1.8 exposures of 0.4 s. The mean diameter of the perforated area was 1.09 +/- 0.11 mm. The lesions were slightly discolored and coagulation of tissue around the perforation was observed. HIFU was successful in perforating cardiac valves. With further refinement, HIFU may prove useful for valvulotomy or valvuloplasty.

Entities:  

Mesh:

Year:  2005        PMID: 15653237     DOI: 10.1016/j.ultrasmedbio.2004.09.009

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  3 in total

1.  Ultrasound attenuation estimation using backscattered echoes from multiple sources.

Authors:  Timothy A Bigelow
Journal:  J Acoust Soc Am       Date:  2008-08       Impact factor: 1.840

2.  High-frequency ultrasound m-mode imaging for identifying lesion and bubble activity during high-intensity focused ultrasound ablation.

Authors:  Ronald E Kumon; Madhu S R Gudur; Yun Zhou; Cheri X Deng
Journal:  Ultrasound Med Biol       Date:  2012-02-15       Impact factor: 2.998

3.  Cavitation-based third ventriculostomy using MRI-guided focused ultrasound.

Authors:  Ryan Alkins; Yuexi Huang; Dan Pajek; Kullervo Hynynen
Journal:  J Neurosurg       Date:  2013-09-27       Impact factor: 5.115

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.